Cidara Therapeutics Inc. (CDTX)
NASDAQ: CDTX
· Real-Time Price · USD
64.86
1.31 (2.06%)
At close: Aug 15, 2025, 3:05 PM
Cidara Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | 302K | 8.77M | 26.35M | 39.07M | 46.38M | 64.02M | 56.66M | 84.68M | 83.29M | 64.29M | 61.29M | 27.63M | 54.27M | 49.57M | 46.08M | 41.42M | 11.95M |
Cost of Revenue | 83.4M | 83.43M | 84.94M | 2.82M | 3.14M | 3.49M | 1.92M | 817K | 467K | 104K | 143K | 151K | 20.62M | 38.3M | 54.11M | 75.2M | 70.96M | 70.87M |
Gross Profit | -90.89M | -90.62M | -83.67M | 23.53M | 35.92M | 42.89M | 62.1M | 55.84M | 84.22M | 83.18M | 64.14M | 61.14M | 7.01M | 15.97M | -4.54M | -29.13M | -29.54M | -58.92M |
Operating Income | -128.16M | -107.95M | -93.37M | -45.26M | -32.33M | -34.06M | -20.59M | -27.79M | -8.39M | -8.68M | -29.72M | -33.22M | -66.18M | -42.29M | -42.26M | -47.03M | -46.53M | -75.51M |
Interest Income | 7.24M | 7.34M | 5.81M | 4.53M | 3.28M | 2.13M | 2M | 1.63M | 1.07M | 449K | 217K | 55K | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -117.1M | -185.59M | -172.44M | -125.62M | -113.94M | -31.94M | -18.6M | -26.16M | -7.32M | -8.23M | -29.53M | -33.23M | -66.29M | -42.46M | -42.47M | -47.3M | -46.85M | -75.86M |
Net Income | -91.32M | -180.73M | -167.58M | -120.88M | -113.52M | -36.47M | -23.13M | -30.89M | -10.82M | -11.59M | -32.91M | -36.33M | -66.31M | -44.37M | -44.36M | -49.19M | -48.74M | -75.86M |
Selling & General & Admin | 24.95M | 23.14M | 22.96M | 22.82M | 21.41M | 20.03M | 18.49M | 14.75M | 16.98M | 17.74M | 18.49M | 20.04M | 18.87M | 19.16M | 18.74M | 17.91M | 16.99M | 16.59M |
Research & Development | 108.72M | 90.56M | 77.55M | 46.03M | 50.93M | 61.41M | 68.69M | 73.39M | 76.1M | 74.22M | 75.52M | 74.47M | 74.94M | 77.4M | 73.09M | 75.2M | 70.96M | 70.87M |
Other Expenses | -5.51M | -5.51M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 128.16M | 108.19M | 100.51M | 68.85M | 72.34M | 81.44M | 87.18M | 88.14M | 93.08M | 91.96M | 94.01M | 94.52M | 93.81M | 96.57M | 91.83M | 93.11M | 87.94M | 87.45M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | 623K | 623K | 623K | 623K | 6K | 26K | 59K | 106K | 162K | 212K | 265K | 321K | 354K |
Selling & Marketing Expenses | -13.31M | -13.36M | -13.36M | -57K | -57K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 128.16M | 193.13M | 187.02M | 156.49M | 160.37M | 84.53M | 88.7M | 88.53M | 93.08M | 91.96M | 94.01M | 94.52M | 93.81M | 96.57M | 91.83M | 93.11M | 87.94M | 87.45M |
Income Tax Expense | n/a | -4.8M | -4.86M | -4.79M | -4.82M | 125K | 181K | 389K | 311K | 168K | 188K | -51K | 131K | 109K | 72K | 39K | -33K | -17K |
Shares Outstanding (Basic) | 15.55M | 14.18M | 9.73M | 6.53M | 4.56M | 4.54M | 4.49M | 4.51M | 4.41M | 3.93M | 3.59M | 3.52M | 2.63M | 3.39M | 3.22M | 2.44M | 2.44M | 2.1M |
Shares Outstanding (Diluted) | 15.55M | 14.18M | 9.73M | 6.53M | 4.56M | 4.54M | 4.53M | 4.51M | 4.51M | 5.06M | 3.59M | 4.43M | 3.46M | 3.41M | 3.22M | 2.48M | 2.97M | 2.35M |
EPS (Basic) | -11.06 | -29 | -29.62 | -25.5 | -24.93 | -8.14 | -5.09 | -7.56 | -2.36 | -4.54 | -10.72 | -12.22 | -23.01 | -14.41 | -17.72 | -22.3 | -23.06 | -35.68 |
EPS (Diluted) | -11.06 | -29 | -29.62 | -25.49 | -24.92 | -8.07 | -5.19 | -7.67 | -2.48 | -3.54 | -9.51 | -11 | -21.68 | -14.27 | -16.69 | -21.28 | -22.14 | -34.69 |
EBITDA | -124.06M | -107.74M | -92.79M | -44.71M | -31.21M | -26.87M | -13.78M | -20.82M | -2.03M | -8.38M | -29.41M | -33.07M | -66.02M | -42.12M | -42.07M | -46.84M | -46.31M | -75.28M |
EBIT | -122.56M | -107.95M | -93M | -44.9M | -31.36M | -27M | -13.9M | -20.93M | -2.15M | -8.51M | -29.56M | -33.22M | -66.18M | -42.29M | -42.26M | -47.03M | -46.53M | -75.51M |
Depreciation & Amortization | 196K | 226K | 233K | 213K | 174K | 518K | 494K | 484K | 499K | 136K | 143K | 151K | 159K | 171K | 189K | 197K | 216K | 227K |